• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

关于国际皮肤科协会联盟与欧洲皮肤病学会合作发布的《光化性角化病治疗的循证和共识（S3）指南》的评论。

Commentary on the "Evidence- and Consensus-Based (S3) Guidelines for the Treatment of Actinic Keratosis" Published by the International League of Dermatological Societies in Cooperation with the European Dermatology Forum.

机构信息

Department of Clinical Social Medicine, Occupational and Environmental Dermatology, Heidelberg University Hospital, Heidelberg, Germany.

Irmgardis Pharmacy, Viersen, Germany.

出版信息

Skin Pharmacol Physiol. 2018;31(3):144-146. doi: 10.1159/000486687. Epub 2018 Apr 3.

DOI:10.1159/000486687
PMID:29614495
Abstract

In 2015, the International League of Dermatological Societies and the European Dermatology Forum published a guideline for the treatment of actinic keratosis, which is classified as an evidence- and consensus-based S3 guideline. From the point of view of the GD Task Force "Licht.Hautkrebs.Prävention," an interdisciplinary expert panel of the Society for Dermopharmacy for the prevention and treatment of skin cancer, this guideline reveals strengths and weaknesses but, in summary, does not meet the claim for an evidence- and consensus-based S3 guideline.

摘要

2015 年，国际皮肤科学会联盟和欧洲皮肤病学会发布了光化性角化病治疗指南，该指南被归类为基于证据和共识的 S3 指南。从“光.皮肤癌.预防”GD 工作组（皮肤科药物治疗学会预防和治疗皮肤癌的跨学科专家小组）的角度来看，该指南虽然有其优缺点，但总体来说，不符合基于证据和共识的 S3 指南的要求。

相似文献

1
Commentary on the "Evidence- and Consensus-Based (S3) Guidelines for the Treatment of Actinic Keratosis" Published by the International League of Dermatological Societies in Cooperation with the European Dermatology Forum.关于国际皮肤科协会联盟与欧洲皮肤病学会合作发布的《光化性角化病治疗的循证和共识（S3）指南》的评论。
Skin Pharmacol Physiol. 2018;31(3):144-146. doi: 10.1159/000486687. Epub 2018 Apr 3.
2
Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version.基于证据和共识的（S3）光化性角化病治疗指南 - 国际皮肤科学会联盟与欧洲皮肤病学会联盟合作 - 简版。
J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2069-79. doi: 10.1111/jdv.13180. Epub 2015 Sep 14.
3
Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum.方法与结果报告——光化性角化病治疗的循证与共识（S3）指南——国际皮肤科学会联盟与欧洲皮肤病学论坛合作制定
J Eur Acad Dermatol Venereol. 2015 Nov;29(11):e1-66. doi: 10.1111/jdv.13179. Epub 2015 Sep 9.
4
Actinic Keratosis, a Chronic, Progressive Disease: Understanding Clinical Gaps to Optimise Patient Management.光化性角化病，一种慢性进行性疾病：了解临床差距以优化患者管理。
Acta Derm Venereol. 2017 Aug 31;97(8):997-998. doi: 10.2340/00015555-2692.
5
European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes).欧洲基于共识的跨学科指南：光化性角化病、上皮紫外线诱导发育不良和皮肤癌前病变的诊断、治疗和预防，代表了欧洲皮肤病肿瘤学会、欧洲皮肤病学会、欧洲皮肤性病学会和医学专家联盟（Union Européenne des Médecins Spécialistes）。
J Eur Acad Dermatol Venereol. 2024 Jun;38(6):1024-1047. doi: 10.1111/jdv.19897. Epub 2024 Mar 7.
6
Online consensus conferences for clinical guidelines development - a survey among participants from the International Guidelines for the Treatment of Actinic Keratosis.用于制定临床指南的在线共识会议——对来自《光化性角化病治疗国际指南》参与者的一项调查
J Eval Clin Pract. 2014 Dec;20(6):853-6. doi: 10.1111/jep.12159. Epub 2014 May 5.
7
Online consensus conferences for the development and update of clinical practice guidelines: A survey among participants of the German S3 guideline on actinic keratosis and cutaneous squamous cell carcinoma.用于制定和更新临床实践指南的在线共识会议：对德国关于光化性角化病和皮肤鳞状细胞癌的S3指南参与者的一项调查
J Dtsch Dermatol Ges. 2021 Apr;19(4):608-610. doi: 10.1111/ddg.14397. Epub 2021 Feb 22.
8
Current regimens and guideline implications for the treatment of actinic keratosis: proceedings of a clinical roundtable at the 2011 Winter Clinical Dermatology Conference.光化性角化病治疗的当前方案及指南意义：2011年冬季临床皮肤病学会议临床圆桌会议纪要
Cutis. 2011 Jul;88(1):suppl 1-8.
9
Comparison of the Treatment Guidelines for Actinic Keratosis: A Critical Appraisal and Review.光化性角化病治疗指南比较：批判性评估与综述
J Cutan Med Surg. 2017 Sep/Oct;21(5):408-417. doi: 10.1177/1203475417708166. Epub 2017 May 16.
10
Comment to: 'Evidence and consensus based (S3) Guidelines for the Treatment of Actinic Keratosis'.对《光化性角化病治疗的循证与共识（S3）指南》的评论
J Eur Acad Dermatol Venereol. 2016 Nov;30(11):e114. doi: 10.1111/jdv.13355. Epub 2015 Sep 25.